Oxcarbazepine for self-mutilating bulimic patients.
Cordás
Táki Athanassios
TA
Tavares
Hermano
H
Calderoni
Douglas Motta
DM
Stump
Gabriela Viegas
GV
Ribeiro
Rafael Bernardon
RB
D000328:Adult; D000437:Alcoholism / Q000150:complications / Q000523:psychology; D000856:Anorexia Nervosa / Q000150:complications / Q000523:psychology; D000927:Anticonvulsants / Q000627:therapeutic use*; D001883:Borderline Personality Disorder / Q000188:drug therapy / Q000523:psychology; D002032:Bulimia / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000150:complications / Q000523:psychology; D005260:Female; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000523:psychology; D000078330:Oxcarbazepine; D011569:Psychiatric Status Rating Scales; D012652:Self Mutilation / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D019966:Substance-Related Disorders / Q000150:complications / Q000523:psychology
D000927:Anticonvulsants; D002220:Carbamazepine; D000078330:Oxcarbazepine